Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

990 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use.
Rossing P, Agarwal R, Anker SD, Filippatos G, Pitt B, Ruilope LM, Fonseca V, Umpierrez GE, Caramori ML, Joseph A, Lambelet M, Lawatscheck R, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Rossing P, et al. Among authors: fonseca v. Diabetes Obes Metab. 2023 Feb;25(2):407-416. doi: 10.1111/dom.14883. Epub 2022 Nov 2. Diabetes Obes Metab. 2023. PMID: 36193847 Free PMC article. Clinical Trial.
beta-blocker use and diabetes symptom score: results from the GEMINI study.
McGill JB, Bakris GL, Fonseca V, Raskin P, Messerli FH, Phillips RA, Katholi RE, Wright JT Jr, Iyengar M, Anderson KM, Lukas MA, Dalal MR, Bell DS. McGill JB, et al. Among authors: fonseca v. Diabetes Obes Metab. 2007 May;9(3):408-17. doi: 10.1111/j.1463-1326.2006.00693.x. Diabetes Obes Metab. 2007. PMID: 17391169 Clinical Trial.
Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial.
Umpierrez GE, Smiley D, Hermayer K, Khan A, Olson DE, Newton C, Jacobs S, Rizzo M, Peng L, Reyes D, Pinzon I, Fereira ME, Hunt V, Gore A, Toyoshima MT, Fonseca VA. Umpierrez GE, et al. Among authors: fonseca va. Diabetes Care. 2013 Aug;36(8):2169-74. doi: 10.2337/dc12-1988. Epub 2013 Feb 22. Diabetes Care. 2013. PMID: 23435159 Free PMC article. Clinical Trial.
Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease.
Thethi TK, Bajwa MA, Ghanim H, Jo C, Weir M, Goldfine AB, Umpierrez G, Desouza C, Dandona P, Fang-Hollingsworth Y, Raghavan V, Fonseca VA. Thethi TK, et al. Among authors: fonseca va. J Diabetes Complications. 2015 Apr;29(3):433-7. doi: 10.1016/j.jdiacomp.2015.01.004. Epub 2015 Jan 13. J Diabetes Complications. 2015. PMID: 25633573 Free PMC article. Clinical Trial.
Real-world evidence of the effectiveness on glycaemic control of early simultaneous versus later sequential initiation of basal insulin and glucagon-like peptide-1 receptor agonists.
Rosenstock J, Ampudia-Blasco FJ, Lubwama R, Peng XV, Boss A, Shi L, Fonseca V. Rosenstock J, et al. Among authors: fonseca v. Diabetes Obes Metab. 2020 Dec;22(12):2295-2304. doi: 10.1111/dom.14154. Epub 2020 Sep 2. Diabetes Obes Metab. 2020. PMID: 32729183 Free PMC article.
990 results